Company intelligence / Profile preview

Avemar

Kunfehértó, Hungary
Ownership
Private
Development stage
Other
01

Overview

Avemar is a biotechnology company centered on the production and scientific validation of its flagship product, a patented fermented wheat germ extract (FWGE). Developed in Hungary, the company's primary offering is utilized globally as a medical food and dietary supplement for cancer patients to support standard oncological treatments. The extract works by inhibiting enzymes involved in the pentose phosphate pathway and modulating the immune system's response to malignant cells. Avemar's research portfolio includes numerous clinical studies across various indications, including colorectal, breast, and lung cancers, as well as autoimmune conditions like rheumatoid arthritis. The company maintains a strong focus on scientific validation, with numerous peer-reviewed publications supporting its mechanism of action and clinical benefits. The product was inspired by the research of Nobel Prize winner Albert Szent-Györgyi and is manufactured under strict GMP standards.

Therapeutic areas
OncologyImmunology
Modalities
Small moleculeBiologic
Industry
Non-Drug Biotech
02

Partnerships

American BioSciences

Beyond the preview

Go deeper on Avemar.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avemar.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call